Total Funding
69
51
Total FundingDebt Financing raised
Growth Score
-7 pts
Heat Score
-21 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
55535
GenomOncology enables precision medicine by translating next generation sequencing data into actionable information.
- Garreth Hippe: Chief Commercial Officer
Brad Wertz: Chief Executive OfficerPast Role: Rosetta, Chief Operating Officer
About the Company
A venture backed and Cleveland, OH based healthcare technology company, GenomOncology is enabling precision medicine by transforming data into actionable information.
We offer the GO Precision Medicine Portfolio - a suite of solutions that addresses the full range of needs for Healthcare Institutions. The portfolio supports technical assay
validation and testing, clinical decision support, collaborative decision support for Molecular Tumor Board workflows and analytics for monitoring and discovery – to enable cancer precision medicine.
